Popular Articles
Teeth Whitening

Terrence Higgins Trust To Run New City & Guilds Course On HIV, UK
HIV and sexual health charity, Terrence Higgins Trust (THT) has just been approved to offer a new City & Guilds course in understanding HIV and AIDS. The course was developed as a partnership between THT and City & Guilds and it is the first of its kind. Courses will be run at locations across the UK.
generic viagra online
Contrary To Guidelines, Compression Stockings Do Not Reduce The Risk Of Blood Clots After Stroke (CLOTS Study)
Thigh-length graduated support stockings (TL-GCS) do not reduce the risk of blood clots in stroke patients. Since guidelines in the UK and many developed nations recommend use of TL-GCS, such guidelines should now be urgently revised. The findings of the CLOTS trial are published in an Article Online First and in an upcoming edition of The Lancet, written by Professor Martin Dennis, University of Edinburgh, UK, and colleagues. Most of the study"s funding came from the UK Medical Research Council. The findings are to be announced during this week"s European Stroke Conference, Stockholm, Sweden.
plastic surgery before after
News of the day
Avastin(R) (bevacizumab) Now Approved For Use In Combination With Docetaxel For The First Line Treatment Of Metastatic Breast Cancer, UK
More patients with metastatic breast cancer could benefit from Avastin (bevacizumab) as a result of a broader label announced by the European Commission that allows bevacizumab to be combined with either docetaxel or paclitaxel chemotherapy1. This is an important announcement, as although bevacizumab has been approved for use in the UK in combination with paclitaxel for the treatment of metastatic breast cancer since March 2007, a higher proportion of metastatic breast cancer patients in the UK are treated with docetaxel.
Medical Devices

Researchers Find A Way To Reduce Patient Radiation Dose During Pulmonary CT Angiography

While screening for possible pulmonary emboli using pulmonary CT angiography, a new study shows that radiologists can effectively lower the patient radiation dose by approximately 44% and improve vascular enhancement without deterioration of image quality, according to a study performed at Brigham and Women"s Hospital and Harvard Medical School, Boston, MA. A total of 400 patients believed to have a pulmonary embolism were evaluated using pulmonary CT angiography. Two hundred patients were evaluated using the standard peak kilovoltage setting of 130 or 120 kVp and the other 200 patients were evaluated using a low peak kilovoltage setting of 110 or 100 kVp. "Results showed that lowering the peak kilovoltage setting by 20-kVp lead to superior vascular enhancement without deterioration of image quality allowing us to effectively reduce the patient radiation dose," said Shin Matsuoka, MD, lead author of the study. "CT has become an essential tool for the diagnosis of pulmonary embolism. However because of the high percentage of negative results, radiation exposure has become an important issue. Our study shows that lowering the kilovoltage setting may be an effective method of lowering the radiation dose for most patients," he said. "Lowering the kilovoltage setting is something that could be easily incorporated into daily clinical practice because there is no additional equipment needed and there are no extra costs," said Dr. Matsuoka. This study appears in the June issue of the American Journal of Roentgenology. About ARRS The American Roentgen Ray Society (ARRS) was founded in 1900 and is the oldest radiology society in the United States. Its monthly journal, the American Journal of Roentgenology, began publication in 1906. Radiologists from all over the world attend the ARRS annual meeting to participate in instructional courses, scientific paper presentations and scientific and commercial exhibits related to the field of radiology. The Society is named after the first Nobel Laureate in Physics, Wilhelm Rē¶entgen, who discovered the x-ray in 1895. American Roentgen Ray Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):